Search results for "proteolytic enzyme"

showing 10 items of 60 documents

Naturally occurring hemolysins in the coelomic fluid of Holothuria polii delle chiaie (Echinodermata).

1979

Abstract The coelomic fluid of Holothuria polii D.Ch contains hemolytic activity against erythrocytes of several vertebrate species. The hemolytic potency depends upon calcium ion concentration and varies according to erythrocyte source and cell number in the reaction mixture. Absorption experiments with formalinized rabbit erythrocytes suggest that hemolytic activity is not specific. Its heat lability, water insolubility at low pH values, and sensitivity to proteolytic enzymes suggest that hemolytic activity resides in protein molecules. The activity, maximal in alkaline media, appears to depend up time and temperature.

ErythrocytesCations DivalentSea CucumbersImmunologyDose-Response Relationship Immunologicchemistry.chemical_elementCalciumHemolysisHemolysin ProteinsPotencyAnimalsbiologyLabilityProteolytic enzymesTemperatureHemolysinExudates and TransudatesHydrogen-Ion Concentrationbiology.organism_classificationKineticschemistryBiochemistryCoelomAbsorption (chemistry)HolothuriaDevelopmental BiologyEchinodermataDevelopmental and comparative immunology
researchProduct

In Vitro Bioactivity of Astaxanthin and Peptides from Hydrolisates of Shrimp (Parapenaeus longirostris) By-Products: From the Extraction Process to B…

2021

Non-edible parts of crustaceans could be a rich source of valuable bioactive compounds such as the carotenoid astaxanthin and peptides, which have well-recognized beneficial effects. These compounds are widely used in nutraceuticals and pharmaceuticals, and their market is rapidly growing, suggesting the need to find alternative sources. The aim of this work was to set up a pilot-scale protocol for the reutilization of by-products of processed shrimp, in order to address the utilization of this valuable biomass for nutraceutical and pharmaceuticals application, through the extraction of astaxanthin-enriched oil and antioxidant-rich protein hydrolysates. Astaxanthin (AST) was obtained using …

Fish ProteinsFood Handlingantioxidant activityPharmaceutical ScienceAngiotensin-Converting Enzyme InhibitorsPilot ProjectsXanthophyllsfish oilArticleAntioxidantsMicechemistry.chemical_compoundNutraceuticalPenaeidaeprotein hydrolysatesAstaxanthinDrug Discoveryshrimp by-productsAnimalsHumansFood sciencelcsh:QH301-705.5Pharmacology Toxicology and Pharmaceutics (miscellaneous)ShellfishWaste Productschemistry.chemical_classificationHydrolysisExtraction (chemistry)Proteolytic enzymesSupercritical fluid extractionFatty acidChromatography Supercritical FluidGreen Chemistry Technology3T3 Cellsproteolytic enzymesFibroblastsShrimpastaxanthinOxidative Stresslcsh:Biology (General)chemistrySPDsupercritical fluid extractionRabbitsPeptidesPUFAPolyunsaturated fatty acidMarine Drugs
researchProduct

The mechanism of formamide hydrolysis in water from ab initio calculations and simulations.

2005

The neutral hydrolysis of formamide in water is a suitable reference to quantify the efficiency of proteolytic enzymes. However, experimental data for this reaction has only very recently been obtained and the kinetic constant determined experimentally is significantly higher than that predicted by previous theoretical estimations. In this work, we have investigated in detail the possible mechanisms of this reaction. Several solvent models have been considered that represent a considerable improvement on those used in previous studies. Density functional and ab initio calculations have been carried out on a system which explicitly includes the first solvation shell of the formamide molecule…

FormamideModels MolecularReaction mechanismFormamidesMolecular StructureReaction stepHydrolysisOrganic ChemistryProteolytic enzymesHydrogen BondingGeneral ChemistryReaction intermediateCrystallography X-RayCatalysischemistry.chemical_compoundSolvation shellchemistrySolvent modelsAb initio quantum chemistry methodsComputational chemistryThermodynamicsComputer SimulationChemistry (Weinheim an der Bergstrasse, Germany)
researchProduct

TMPRSS4 is a type II transmembrane serine protease involved in cancer and viral infections.

2012

Abstract Proteolytic enzymes are involved in almost all biological processes reflecting their importance in health and disease. The human genome contains nearly 600 protease-encoding genes forming more than 2% of the total human proteome. The serine proteases, with about 180 members, built the oldest and second largest family of human proteases. Ten years ago, a novel serine protease family named the type II transmembrane family (TTSP) was identified. This minireview summarizes the up-to-date knowledge about the still growing TTSPs, particularly focusing on the pathophysiological functions of the family member type II transmembrane serine protease (TMPRSS) 4. Recent studies provided importa…

GeneticsSerine proteaseTMPRSS6ProteasesClinical BiochemistrySerine EndopeptidasesProteolytic enzymesMembrane ProteinsBiologyBiochemistryTransmembrane proteinSerineBiochemistryVirus DiseasesNeoplasmsbiology.proteinHuman proteome projectAnimalsHumansMolecular BiologyMASP1Biological chemistry
researchProduct

Endothelial cell-matrix interactions.

2002

Dynamic interactions between endothelial cells and components of their surrounding extracellular matrix are necessary for the invasion, migration, and survival of endothelial cells during angiogenesis. These interactions are mediated by matrix receptors that initiate intracellular signaling cascades in response to binding to specific extracellular matrix molecules. The interactions between endothelial cells and their environment are also modulated by enzymes that degrade different matrix components and thus enable endothelial invasion. Recent reports on gene targeting in mice have confirmed the role of two classes of matrix receptors, integrins and cell surface heparan sulfate proteoglycans…

IntegrinsHistologybiologyNeovascularization PathologicAngiogenesisIntegrinProteolytic enzymesNeovascularization PhysiologicMatrix (biology)Matrix metalloproteinaseMatrix MetalloproteinasesCell biologyExtracellular MatrixExtracellular matrixEndothelial stem cellFibronectinMedical Laboratory TechnologyMicebiology.proteinAnimalsHumansEndothelium VascularAnatomyInstrumentationHeparan Sulfate ProteoglycansMicroscopy research and technique
researchProduct

Utilization of hemin and hemoglobin by Vibrio vulnificus biotype 2

1996

The eel pathogen Vibrio vulnificus biotype 2 is able to use hemoglobin (Hb) and hemin (Hm) to reverse iron limitation. In this stud, the adjuvant effect of both compounds on eel pathogenicity has been evaluated and confirmed. Further, we have studied the heme-iron acquisition mechanism displayed by this bacterium. Whole cells were capable of binding Hb and Hm, independently of (i) iron levels in growth medium and (ii) the presence of polysaccharide capsules on bacterial surface. The Hb- and Hm-binding capacity was retained by the outer membrane protein (OMP) fraction and was abolished after proteolytic digestion of OMP samples. Western blotting (immunoblotting) of denatured OMPs revealed th…

IronVibrio vulnificusApplied Microbiology and BiotechnologyMicrobiologyHemoglobinschemistry.chemical_compoundVibrionaceaeAnimalsHemeVibrioEelsVirulenceEcologybiologyProteolytic enzymesbacterial infections and mycosesbiology.organism_classificationVibriochemistryBiochemistryHeminbacteriaHemoglobinCarrier ProteinsBacterial outer membraneBacterial Outer Membrane ProteinsResearch ArticleFood ScienceBiotechnologyHeminApplied and Environmental Microbiology
researchProduct

An NMR Study of the Interaction of 15N-Labelled Bradykinin with an Antibody Mimic of the Bradykinin B2 Receptor

1997

An isotope-edited NMR study of the peptide hormone bradykinin (RPPGFSPFR) bound to the Fab fragment of a monoclonal antibody against bradykinin (MBK3) is reported. MBK3 was previously shown to provide a binding site model of the B2 bradykinin receptor [Haasemann, M., Buschko, J., Faussner, A., Roscher, A. A., Hoebeke, J., Burch, R. M. & Muller-Esterl, W. (1991) Anti-idiotypic antibodies bearing the internal image of a bradykinin epitope, J. Immunol. 147, 3882-3892]. Bradykinin was obtained in a uniformly 15N-labelled form using recombinant expression of a fusion protein consisting of the glutathione-binding domain of glutathione S-transferase fused to residues 354-375 of the high-molecular-…

Magnetic Resonance SpectroscopyReceptor Bradykinin B2Protein ConformationStereochemistryRecombinant Fusion ProteinsBradykininIn Vitro TechniquesBradykininBiochemistryImmunoglobulin Fab FragmentsMicechemistry.chemical_compoundAnimalsHumansAmino Acid SequenceBradykinin receptorDNA PrimersKininogenBinding SitesBase SequenceNitrogen IsotopesChemistryReceptors BradykininImmunoglobulin Fab FragmentsProteolytic enzymesAntibodies MonoclonalNuclear magnetic resonance spectroscopyB2 Bradykinin ReceptorTwo-dimensional nuclear magnetic resonance spectroscopyProtein BindingEuropean Journal of Biochemistry
researchProduct

Synthesis of Tetrapeptide p‐nitrophenylanilides containing dehydroalanine and dehydrophenylalanine and their influence on cathepsin C activity

2001

Three dehydrotetrapeptides of rationally varying structure were prepared and tested as affectors of cathepsin C. These compounds appeared to be substrates of the enzyme, being equipotent with their classical counterparts. Thus, replacement of amino acid in a short peptide by corresponding dehydroamino acid does not prevent cathepsin C in recognizing dehydropeptide as its substrate. Copyright © 2001 European Peptide Society and John Wiley & Sons, Ltd.

Magnetic Resonance SpectroscopyStereochemistryPhenylalaninePeptideBiochemistryCathepsin CCathepsin Cdipeptidyl-peptidase Ichemistry.chemical_compoundStructural BiologyDehydroalanineDrug DiscoveryAnimalsAnilidesAmino AcidsMolecular BiologyPharmacologyCathepsinchemistry.chemical_classificationAlanineTetrapeptideChemistryOrganic ChemistryProteolytic enzymesdehydroamino acidsGeneral Medicineproteolytic enzymesAmino acidEnzymeModels ChemicalBiochemistryMolecular MedicineCattleOligopeptidesSpleenJournal of Peptide Science
researchProduct

Amylase release from streptolysin O-permeabilized pancreatic acinar cells. Effects of Ca2+, guanosine 5'-[gamma-thio]triphosphate, cyclic AMP, tetanu…

1992

The molecular requirements for amylase release and the intracellular effects of botulinum A toxin and tetanus toxin on amylase release were investigated using rat pancreatic acinar cells permeabilized with streptolysin O. Micromolar concentrations of free Ca2+ evoked amylase release from these cells. Maximal release was observed in the presence of 30 microM free Ca2+. Ca(2+)-stimulated, but not basal, amylase release was enhanced by guanosine 5′-[gamma-thio]triphosphate (GTP[S]) (3-4 fold) or cyclic AMP (1.5-2 fold). Neither the two-chain forms of botulinum A toxin and tetanus toxin, under reducing conditions, nor the light chains of tetanus toxin, inhibited amylase release triggered by Ca2…

MaleBotulinum ToxinsCell Membrane PermeabilityClostridium tetanimedicine.disease_causeBiochemistryNorepinephrineBacterial ProteinsTetanus ToxinAcinar cellmedicineCyclic AMPNeurotoxinAnimalsAmylaseMolecular BiologyPancreasbiologyToxinProteolytic enzymesRats Inbred StrainsCell BiologyRatsBiochemistryGuanosine 5'-O-(3-Thiotriphosphate)AmylasesStreptolysinsbiology.proteinClostridium botulinumStreptolysinCalciumResearch Article
researchProduct

Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study

2011

Background and objectives: Guidelines indicate a plasma HIV-1 RNA load of 500-1000 copies/mL as the minimal threshold for antiretroviral drug resistance testing. Resistance testing at lower viral load levels may be useful to guide timely treatment switches, although data on the clinical utility of this remain limited. We report here the influence of viral load levels on the probability of detecting drug resistance mutations (DRMs) and other mutations by routine genotypic testing in a large multicentre European cohort, with a focus on tests performed at a viral load <1000 copies/mL. Methods: A total of 16511 HIV-1 reverse transcriptase and protease sequences from 11492 treatment-experienced …

MaleDrug ResistanceHIV InfectionsDrug resistanceCohort Studies0302 clinical medicineGenotypeHIV InfectionPharmacology (medical)030212 general & internal medicineViral0303 health sciencesProteolytic enzymesGenotypic testing; HIV; Viral load; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Cohort Studies; Europe; Female; Genotype; HIV Infections; HIV-1; Humans; Male; RNA Viral; Viral Proteins; Drug Resistance Viral; Mutation Missense; Viral Load; Pharmacology; Pharmacology (medical); Infectious DiseasesViral LoadGenotypic testing3. Good healthEuropeInfectious DiseasesCohortRNA ViralFemaleViral loadCohort studyHumanMicrobiology (medical)AdultGenotypeAnti-HIV AgentsMutation MissenseBiologySettore MED/17 - MALATTIE INFETTIVE03 medical and health sciencesViral ProteinsSDG 3 - Good Health and Well-beingDrug Resistance ViralHumansViral ProteinPharmacology030306 microbiologyHIVAnti-HIV AgentVirologyReverse transcriptaseCD4 Lymphocyte CountRegimenHIV; genotypic testing; viral loadGenotypic testing; HIV; Viral load; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Cohort Studies; Drug Resistance Viral; Europe; Female; Genotype; HIV Infections; HIV-1; Humans; Male; Mutation Missense; RNA Viral; Viral Load; Viral ProteinsImmunologyMutationHIV-1RNAMissenseCohort Studie
researchProduct